Kajal Synthetics & Silk Mills Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE -0.82 %
- ROE -10.1 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 129 to 60.8 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -58.0% over past five years.
- Company has a low return on equity of -11.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.10 | 1.23 | 0.55 | 0.12 | 2.03 | 5.24 | 4.59 | 1.86 | 0.57 | 0.08 | 0.13 | 0.06 | |
| 0.03 | 0.68 | 0.05 | 0.07 | 0.24 | 0.54 | 8.59 | 0.29 | 0.30 | 0.32 | 0.35 | 0.39 | |
| Operating Profit | 1.07 | 0.55 | 0.50 | 0.05 | 1.79 | 4.70 | -4.00 | 1.57 | 0.27 | -0.24 | -0.22 | -0.33 |
| OPM % | 97.27% | 44.72% | 90.91% | 41.67% | 88.18% | 89.69% | -87.15% | 84.41% | 47.37% | -300.00% | -169.23% | -550.00% |
| 0.01 | 0.00 | 0.02 | 0.28 | 0.39 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.96 | 7.47 | 7.26 | 5.23 | 3.84 | 3.00 | 2.29 | 1.82 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.08 | 0.55 | 0.52 | 0.33 | 0.22 | -2.77 | -11.26 | -3.61 | -3.57 | -3.24 | -2.51 | -2.15 |
| Tax % | 32.41% | 70.91% | 32.69% | 6.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.73 | 0.16 | 0.35 | 0.31 | 0.22 | -2.77 | -11.26 | -3.61 | -3.57 | -3.24 | -2.51 | -2.15 | |
| EPS in Rs | ||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -20% |
| 5 Years: | -58% |
| 3 Years: | -53% |
| TTM: | -54% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -11% |
| 3 Years: | -12% |
| Last Year: | -10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Reserves | 21.07 | 21.23 | 21.57 | 21.88 | 22.10 | 127.40 | 32.59 | 36.53 | 25.19 | 19.35 | 19.59 | 19.14 |
| 0.00 | 0.00 | 0.00 | 0.00 | 53.00 | 57.00 | 46.00 | 46.30 | 29.10 | 31.60 | 16.60 | 20.70 | |
| 0.04 | 0.04 | 0.02 | 0.01 | 0.15 | 0.03 | 1.44 | 1.63 | 2.45 | 3.04 | 2.26 | 0.06 | |
| Total Liabilities | 23.10 | 23.26 | 23.58 | 23.88 | 77.24 | 186.42 | 82.02 | 86.45 | 58.73 | 55.98 | 40.44 | 41.89 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.69 | 5.77 | 17.32 | 23.41 | 23.77 | 150.42 | 57.16 | 64.38 | 58.20 | 55.60 | 40.32 | 41.76 |
| 18.41 | 17.49 | 6.26 | 0.47 | 53.47 | 36.00 | 24.86 | 22.07 | 0.53 | 0.38 | 0.12 | 0.13 | |
| Total Assets | 23.10 | 23.26 | 23.58 | 23.88 | 77.24 | 186.42 | 82.02 | 86.45 | 58.73 | 55.98 | 40.44 | 41.89 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.19 | 1.60 | 0.00 | 0.00 | 10.51 | -1.29 | 18.58 | -2.61 | -3.24 | -4.29 | |||
| 0.00 | -1.73 | 0.00 | 0.00 | 1.44 | 0.37 | -1.55 | 0.05 | 18.09 | 0.27 | |||
| 0.00 | 0.00 | 0.00 | 0.00 | -11.00 | 0.30 | -17.20 | 2.50 | -15.00 | 4.10 | |||
| Net Cash Flow | -1.19 | -0.13 | 0.00 | 0.00 | 0.95 | -0.62 | -0.18 | -0.06 | -0.16 | 0.08 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 196.54 | 60.83 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 196.54 | 60.83 |
| Working Capital Days | 6,029.14 | 5,157.48 | 4,107.91 | 1,247.08 | 9,312.00 | 2,499.97 | 1,781.26 | 78.49 | -1,427.98 | -13,687.50 | -6,064.62 | -182.50 |
| ROCE % | 4.76% | 2.38% | 2.22% | 1.39% | 4.32% | -3.00% | 1.96% | 0.38% | -0.44% | -0.48% | -0.82% |
Documents
Announcements
-
Non-Applicability Of Provision Of Reg 23(9) Of SEBI (LODR) Regulations, 2015
9 Oct - Regulation 23(9) not applicable; equity Rs199.20L, net worth -Rs791.70L as on Mar 31, 2025.
-
Compliance-57 (5) : intimation after the end of quarter
9 Oct - Company reports no interest/dividend/principal payments in July-September 2025 due to no such instruments.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Oct - RTA confirmation under Reg 74(5) for dematerialisation, quarter ended 30 September 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
1 Oct - Appointed Arvind Kumar Newar and Manju Khator as independent directors (1 Oct 2025–30 Sep 2030); committees reconstituted.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 01.10.2025
1 Oct - Appointed Arvind Kumar Newar and Manju Khator as independent directors for five-year terms from 01.10.2025; committees reconstituted.
Annual reports
No data available.